CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Biologics Operations sold 48,912 shares at an average $2.55 ($124,576)
- 4 Grant or award SVP, Biologics Operations acquired 150,000 shares (grant or award)
- 4 Returned to the company Director returned 13,333 shares (to the company)
- 4 Open-market buy President and CEO bought 613 shares at $2.40 ($1,471)
- 4 Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Grant or award President and CEO acquired 510,434 shares (grant or award)
- 4 Grant or award Exec. VC - Strategic Dev. acquired 510,434 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Open-market buy President and CEO bought 586 shares at $2.41 ($1,412)
- 4 Insider Changes in Ownership
- 4 Returned to the company SVP, Biologics Operations returned 54,036 shares (to the company)
- 4 Returned to the company SVP, Biologics Operations returned 25,804 shares (to the company)
Page 9 of 15 · 289 filings